Search

The American Society for Colposcopy and Cervical Pathology (ASCCP) Consensus Guidelines for the abnormal cervical cancer screening tests is undoubtedly the most international and authoritative. The ASCCP consensus guidelines fomulated by a steering committee of nationally recognized experts in cervical cancer prevention by data collection, literature research and online discussion updated the 2006 ASCCP consensus guidelines. Data from almost 1.4 million women who were followed up from 2003 January to 2010 December in the Kaiser Permanente Northern California Medical Care Plan(KPNC) provided impotrant evidence on risk after abnormal tests. In this paper, we presented the evidence-based interpretation of the concensus guidelines in order to provide better advision for the management of abnomal cervical cancer screening tests. [ABSTRACT FROM AUTHOR]

Cervical cancer with definite pathogenic factors exits longer and reversible premalignant lesions which can be intervened by medical methods to decrease the morbidity and mortality. With the development of cervical cancer screening, more and more women especially young women were found with cervical intraepithelial neoplasia (CIN). The management and intervention of precancerous lesions is an important link to prevent invasive carcinoma. Combined with American Society for Colposcopy and Cervical Pathology (ASCCP) in 2013 promulgated "2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors", we interpretated the management of cervical precancerous lesions. The uptated guidelines of great importance to direct the clinical practice prescribed the management of CIN and highlighted the follow-up value of co-test. [ABSTRACT FROM AUTHOR]